Taeksang Kwon (Han Geul Byun)

Publication Activity (10 Years)

Years Active: 2020-2021
Publications (10 Years): 2

Top Topics

Metastatic Breast Cancer

Cross Sectional

Top Venues

Applied health economics and health policy

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Taeksang Kwon, Minyoung Jang, Hyun Kyeong Yoo, James Potter, Taek Sang Kwon
Budget Impact Analysis of the Introduction of Subcutaneous Infliximab (CT-P13 SC) for the Treatment of Rheumatoid Arthritis in the United Kingdom. Applied health economics and health policy 19 (5) (2021)
Minyoung Jang, Steven R A Simoens, Taeksang Kwon
Budget Impact Analysis of the Introduction of Rituximab and Trastuzumab Intravenous Biosimilars to EU-5 Markets. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 35 (1) (2020)